Meeting Banner
Abstract #4719

The Radiomic Signature as a Prognostic Biomarker for Locally Advanced Rectal Cancer

Yuchen Zhang1, Yankai Meng2, Hongmei Zhang2, Chunwu Zhou2, Di Dong3, Mengjie Fang3, Yali Zang3, Zhenyu Liu3, Jie Tian4, Di Dong3, Di Dong3, and Di Dong3

1University of Electronic Science and Technology of China, Beijing, China, 2Department of Radiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China., Beijing, China, 3CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing P.R. China; University of Chinese Academy of Sciences, Beijing P.R. China., Beijing, China, 4CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China

Radiomics uses a large number of medical imaging features and can demonstrate voxel-wise intratumor heterogeneity. We calculated the radiomic signature for each patient using a weighted linear combination of the radiomic features selected by machine learning methods. The study endpoint was DFS, defined as the interval between TME surgery and disease progression, which included tumor local recurrence, distant metastasis, or death, or the date of the last follow-up visit (censored). The association between the radiomic signature and DFS was explored. Then, the three models were built to estimate the DFS in patients.

This abstract and the presentation materials are available to members only; a login is required.

Join Here